跳到正文
ECA GMP News·· 7 天前AI 评分71

ECA分析质量控制组发布OOS结果指南3.0版

ECA's Analytical Quality Control Group Publishes Version 3.0 of the Out of Specification (OOS) Guidance

AI 导读

ECA分析质量控制组于2026年11月发布OOS结果实验室数据管理指南3.0版,自2013年8月的2.1版起对全文作了全面修订并扩大适用范围。新版分为9章和7个附录,新增假设检验清单、重测与重取样清单及实践案例附录,全文36页、15篇参考文献,并纳入调查阶段转换、根本原因判定、统计解释和合同实验室接口等议题。

正文 · 原文

In November 2026, the ECA Analytical Quality Control Group (AQCG) published Version 3.0 of its Laboratory Data Management Guidance "Out of Specification (OOS) Results". Starting from Version 2.1 of August 2013, the entire guideline has been thoroughly revised, and both its scope and its length have been significantly expanded. The document was authored by Dr Christopher Burgess and Margarita Sabater. The technical review was performed by Dr Joachim Ermer. Scope & ApplicationThe intent of the guideline is to help organizations establish procedures that are consistent, evidence-based and inspection-defensible. The Scope & Application section states:"This guideline is confined to the analytical testing laboratory and does specifically include; Batch release testing and testing of starting materials. In-Process Control testing if data are used as part of for batch evaluation or certification Stability studies on IMPs and marketed products and or active pharmaceutical ingredients (primary, commitment, ongoing and product lifecycle stability) Batches for clinical trials or IMPs.The current revision also incorporates recurring questions identified through AQCG stakeholder survey feedback, particularly around investigation phase transitions, hypothesis testing, retesting and resampling, root cause determination, statistical interpretation, Quality oversight, contract laboratory interfaces and practical decision support."Chapter StructureVersion 3.0 is organised into the following main chapters:1. Overview of Laboratory Data Management & the Analytical Process 2. OOS Investigation Process and Decision Pathways 3. Laboratory Investigations of OOS Results 4. Retesting, Repeat Testing, Resampling and Replicate Testing 5. Statistical Interpretation and Reportable Results 6. Root Cause Assessment and Human Error 7. Interface with OOE, OOT and Trending 8. Contract Laboratory Responsibilities 9. Regulatory & Technical References Three new appendices have been added (Appendices 4 to 6). Appendices 1 to 3 have been retained, with some sections revised or expanded. The Technical Glossary, now Appendix 7, has also been expanded:Appendix 1; Checklist for Phase 1a OOS investigation Appendix 2; Example calculation of a 95% Confidence Limit Appendix 3; Example calculation of a robust mean and robust 95% Confidence Limit (H15 method) Appendix 4; Hypothesis testing checklist Appendix 5; Retesting and resampling checklist Appendix 6; Practical case studies and investigation examples Appendix 7; Technical Glossary In total, the document comprises 36 pages, 4 figures, 5 tables and 15 references. DownloadVersion 3.0 of the OOS Guidance is available for download in the AQCG members' area. The members' area also provides access to the other documents developed by the group. Further information is available on the group's website, where interested professionals can also apply for free membership.PharmaLab 2026The AQCG will also present these topics at PharmaLab 2026, which takes place from 23 to 25 November 2026 at the new venue in Darmstadt, close to Frankfurt International Airport. The congress offers several parallel conferences, poster presentations and three pre-conference workshops.This year, the AQCG is organising one of the pre-conference workshops and a dedicated one-day conference track. The pre-conference workshop on 23 November, "Data Quality Management of Aberrant Results: Handling Out of Specification (OOS) and Out of Trend (OOT) Results", will also provide an opportunity to discuss the new guidance. Participants of the pre-conference workshop will receive the new guidance as a free download.

来源:ECA GMP News · gmp-compliance.org

事件后续 · 1

查看事件全部